-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

903. Health Services and Quality Improvement –Myeloid Malignancies: Poster II

Symposia: Health Services and Quality Improvement –Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Zoe Begun1*, Emilie Thompson, MD1*, Tingting Zhan, PhD2*, Gina Keiffer, MD3, Margaret Kasner, MD3 and Lindsay Wilde, MD4

1Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
2Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
3Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Jefferson Health, Philadelphia, PA
4Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Jefferson Health, Philadelphia, PA

Maria-Jose Ribeiro, MD1, Samantha McClelland, PharmD2*, James Duvel, PharmD2*, Mark Geraci, PharmD, BCOP3*, Donna Leslie, Pharm.D4*, Kourtney D Laplant, PharmD, BCOP5*, Marshall Tague, PharmD, BCOP6* and Bernadette B. Heron, PharmD, BCOP7*

1Atlanta VAMC, Decatur, GA
2VA Great Lakes Health Care Systems VISN 12, Hines
3Department of Veterans Affairs, Pharmacy Benefits Management, Hines, IL
4VA Great Lakes Health Care System VISN 12, Hines
5Pharmacy Benefits Management, Veterans Integrated Service Network 8, Tampa, FL
6Iowa City VA Medical Center, Iowa City, IA
7Department of Veterans Affairs, Hines, IL

Anna B. Halpern, MD1,2, Jessica M Sugalski, MPPA3*, Lindsey Bandini3*, F. Marc Stewart, MD4 and Roland B. Walter, MD, PhD, MS5,6,7

1University of Washington, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3National Comprehensive Cancer Network® (NCCN®), Plymouth Meeting, PA
4Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
5Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
6Translational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA
7Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA

Nicholas Viiala, MBBS FRCPA FRACP1,2, Omali Pitiyarachchi, MBBS, BSc, FRACP3*, Heather Range, BPharm4*, Joseph Descallar1,5*, Rebecca Han Nguyen, MD1,6*, John Dang Trinh Nguyen, MD7*, Ashley Kate McEwan, MBChB, FRACP FRCPA1,2*, Bartlomiej Getta, MBBS1,2 and Lindsay Cameron Dunlop, MBBS, PhD, FRACP, FRCPA2,8*

1South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
2Department of Haematology, Liverpool Hospital, Liverpool, AUS
3School of Biomedical Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, AUS
4Department of Pharmacy, Liverpool Hospital, Liverpool, Australia
5Ingham Institute for Applied Medical Research, Liverpool NSW, Australia
6Department of Haematology, Liverpool Hospital, Liverpool, Australia
7Liverpool Hospital, Sydney, Australia
8Western Sydney University, Liverpool, NSW, AUS

Glen Peterson, DNP1*, Susan Moore, PhD, MSPH1,2*, Sarah Montoya, BA3*, Carolyn Hutchison, MS4*, Katherine Hoople, MPH2* and Clayton Smith, MD4

1School of Medicine, University of Colorado, Aurora, CO
2Colorado School of Public Health, Aurora, CO
3University of Colorado Anschutz Research Administration, Aurora, CO
4CU Innovations, University of Colorado, Aurora, CO

Joseph Farinella, MS1*, Lauren M Granat, DO, MS2, Hong Li, MS3*, Sharon M Caroniti1*, Pranay S. Hegde, BS4*, Matt Kalaycio, MD5, Ronald Sobecks, MD6, Claudio Brunstein, MD, PhD5, Craig S Sauter, MD5 and Betty K. Hamilton, MD7

1Blood and Marrow Transplant, Cleveland Clinic, Cleveland, OH
2Internal Medicine, Cleveland Clinic, Cleveland, OH
3Department of Biostatistics and Quantitative Health Sciences, Cleveland Clinic, Cleveland
4Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, Cleveland, OH
5Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Blood and Marrow Transplant, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Ivan Civettini, MD1,2*, Arianna Zappaterra, MD1,2*, Daniele Ramazzotti, PhD3*, Bianca Maria Granelli, MD1,2*, Giovanni Rindone, MD1,2*, Andrea Aroldi, MD4*, Stefano Bonfanti, MD1,2*, Federica Colombo, MD1,2*, Marilena Fedele, MD2*, Giovanni Grillo5*, Matteo Parma, MD2*, Paola Perfetti, MD2*, Elisabetta Terruzzi, MD2*, Carlo Gambacorti-Passerini, MD2,6 and Fabrizio Cavalca2*

1Department of Medicine and Surgery, University Milano-Bicocca, Monza, Italy
2Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
3Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
4Hematology Division and Bone Marrow Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
5Stem Cell Transplantation, Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milano, Italy
6University Milano-Bicocca, Monza, Italy

Priyanka Pullarkat, MD1*, Yael Flamand, MS2*, Harish Seethapathy, MD3*, Meghan Sise, MD, MS3*, Andrew M. Brunner, MD4, Amir T. Fathi, MD4 and Rupa Narayan, MD4

1Department of Medicine, Massachusetts General Hospital, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Division of Nephrology, Massachusetts General Hospital, Boston, MA
4Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA

Maggie Wong, MBBS, MRCP1*, Zhi Yao Chan2*, Mei Yin Quek3*, Alexis Koh4*, Constance Teo5*, Jinny Foo6*, Cheng Ean Chee7*, Andrea Wong7*, Samuel Ow7*, Joey Tay6*, Vivian Luah8*, Xiao Shi Saw5*, Yuet Peng Wong5*, Meng Tuck Lee6*, Jolene Lee6*, Chee-Yen Lin, MD7*, Wei-Ying Jen, MD, FRCPath, MA7,9*, Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP10 and Janelle Chua6*

1Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore, Singapore
2Division of Oncology Pharmacy, National University Cancer Institute, Singapore, Singapore, Singapore
3Operations & Administration, National University Cancer Institute, Singapore, Singapore, Singapore
4Clinical Support Services – Medical Social Work, National University Cancer Institute, Singapore, Singapore, Singapore
5Division of Oncology Pharmacy, National University Cancer Institute, Singapore, Singapore
6Operations & Administration, National University Cancer Institute, Singapore, Singapore
7Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
8Clinical Support Services – Medical Social Work, National University Cancer Institute, Singapore, Singapore
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
10Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Zack Pemberton-Whiteley1*, Samantha Nier, MSc1*, David Mott, PhD2*, Chris Skedgel2* and Jake Hitch2*

1Acute Leukemia Advocates Network, Bern, Switzerland
2The Office of Health Economics, London, United Kingdom

Prajwal Dhakal, MBBS1, Christopher Wichman, PhD2*, Bunny Pozehl3*, Kalika Mahato4* and Vijaya Raj Bhatt, MD5

1University of Iowa, Iowa city, IA
2University of Nebraska Medical Center, Omaha, NE
3College of Nursing- Omaha Division, University of Nebraska Medical Center, Omaha
4University of Nebraska Medical Center, Omaha
5The Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE

Max F. Kelsten, MD1*, Adam Yuh Lin, MD, PhD2, Natalie K. Heater, MD1* and Aashish K. Didwania, MD1*

1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
2Division of Hematology-Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

Yomna Eissa1*, Eshrak Al-Shaibani1*, Carol Chen2*, Shiyi Chen1*, Igor Novitzky-Basso, MD1*, Arjun D. Law, MD1*, Wilson Lam, MD1, Fotios Michelis, MD, PhD1*, Auro Viswabandya, MD1, Armin Gerbitz, MD, PhD1*, Ivan Pasic, MD1*, Dennis D. H. Kim1, Jeffrey H. Lipton, MD, PhD1, Jonas Mattsson, MD, PhD1* and Rajat Kumar, MD, FRCPC1

1University Health Network / Princess Margaret Cancer Centre, Toronto, ON, Canada
2HANS MESSNER ALLOGENEIC TRANSPLANT PROGRAM, PRINCESS MARGARET CANCER CENTRE, UNIVERSITY HEALTH NETWORK, Toronto, ON, Canada

*signifies non-member of ASH